Skip to main content

IART

Stock
Health Care
Medical Devices

Performance overview

IART Price
Price Chart

Forward-looking statistics

Beta
0.90
Risk
53.54%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.

Company info

SectorHealth Care
IndustryMedical Devices
Employees4K
Market cap$2.4B

Fundamentals

Enterprise value—
Revenue—
Revenue per employee—
Profit margin—
Debt to equity—

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)—
Dividend per share—
Revenue per share—
Avg trading volume (30 day)—
Avg trading volume (10 day)—
Put-call ratio—

Macro factor sensitivity

Growth+2.7
Credit+2.9
Liquidity-1.1
Inflation-0.1
Commodities+0.8
Interest Rates-1.9

Valuation

Dividend yield0.00%
PEG Ratio—
Price to sales—
P/E Ratio7.87
Enterprise Value to Revenue—
Price to book—

Upcoming events

Next earnings dayMay 5, 2025
Next dividend day—
Ex. dividend day—

News

IART Stock May Rise on First Enrollment in AERA Pediatric Registry

Integra enrolls first pediatric patient in AERA registry to evaluate real-world use of its ETBD system and expand ENT market presence.

Zacks Investment Research (July 3, 2025)
Integra LifeSciences Analysts Cut Their Forecasts After Q2 Results

Integra LifeSciences IART reported upbeat second-quarter earnings and lowered its FY24 guidance below estimates on Monday.

Benzinga (July 30, 2024)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free